A detailed history of Wrapmanager Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Wrapmanager Inc holds 9,903 shares of BMY stock, worth $400,576. This represents 0.15% of its overall portfolio holdings.

Number of Shares
9,903
Holding current value
$400,576
% of portfolio
0.15%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

BUY
$47.98 - $54.4 $475,145 - $538,723
9,903 New
9,903 $537,000
Q2 2023

Aug 08, 2023

BUY
$63.71 - $70.74 $637 - $707
10 Added 0.14%
7,117 $455,000
Q1 2023

May 08, 2023

SELL
$65.71 - $74.53 $25,692 - $29,141
-391 Reduced 5.21%
7,107 $492,000
Q4 2022

Feb 06, 2023

SELL
$68.48 - $81.09 $165,584 - $196,075
-2,418 Reduced 24.38%
7,498 $539,000
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $112 - $66,466
865 Added 9.56%
9,916 $705,000
Q2 2022

Aug 05, 2022

SELL
$72.62 - $79.98 $296,507 - $326,558
-4,083 Reduced 31.09%
9,051 $697,000
Q1 2022

May 10, 2022

BUY
$61.48 - $73.72 $334,328 - $400,889
5,438 Added 70.66%
13,134 $959,000
Q4 2021

Feb 07, 2022

BUY
$53.63 - $62.52 $157,457 - $183,558
2,936 Added 61.68%
7,696 $480,000
Q3 2021

Nov 10, 2021

BUY
$59.17 - $69.31 $31,655 - $37,080
535 Added 12.66%
4,760 $282,000
Q2 2021

Aug 04, 2021

BUY
$61.91 - $67.42 $8,853 - $9,641
143 Added 3.5%
4,225 $282,000
Q1 2021

May 10, 2021

SELL
$59.34 - $66.74 $148,231 - $166,716
-2,498 Reduced 37.96%
4,082 $258,000
Q4 2020

Feb 08, 2021

SELL
$57.74 - $65.43 $35,914 - $40,697
-622 Reduced 8.64%
6,580 $408,000
Q3 2020

Nov 12, 2020

BUY
$57.43 - $63.64 $97,343 - $107,869
1,695 Added 30.78%
7,202 $434,000
Q2 2020

Aug 11, 2020

BUY
$54.82 - $64.09 $301,893 - $352,943
5,507 New
5,507 $324,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $86B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Wrapmanager Inc Portfolio

Follow Wrapmanager Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wrapmanager Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wrapmanager Inc with notifications on news.